Stocks › AXSM
Axsome Therapeutics AXSM
US equityMarket cap rank #1751
$129.36 −$6.32 (-4.66%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $129.36 0.00%
Open$133.92
Prev close$135.68
Day range$128.23 – $135.09
Volume811.8K
Market cap$6.80B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$259.69M+51.9% YoY
Operating profit-$13.45M+59.2% YoY
Net profit-$12.88M+72.7% YoY
Diluted EPS-$0.25+73.4% YoY
Free cash flow-$9.67M-1,078.3% YoY
Operating cash flow-$9.47M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin93.2%
Operating margin-18.9%
Net margin-18.2%
Return on equity-175.6%
Return on assets-21.0%
Return on invested capital-49.5%
Current ratio1.42
Liabilities / assets87.2%
Cash & investments$313.86M
Total debt$218.01M
Net cash (debt)$95.85M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $259.69M | $218.38M | $191.20M | $638.50M | $196.00M |
| Total Operating Revenue | $259.69M | $218.38M | $191.20M | $638.50M | $196.00M |
| Cost of Revenue | $17.80M | $13.56M | $14.73M | $47.48M | $12.33M |
| Gross Profit | $241.89M | $204.81M | $176.48M | $591.02M | $183.67M |
| Operating Expense | $255.34M | $255.95M | $239.25M | $760.25M | $219.70M |
| Selling and Admin Expenses | $203.11M | $208.14M | $185.00M | $570.60M | $169.30M |
| Research & Development | $50.62M | $46.23M | $52.68M | $183.28M | $48.79M |
| Depreciation & Amortization & Depletion | $1.61M | $1.59M | $1.57M | $6.38M | $1.61M |
| -Depreciation & Amortization | $1.61M | $1.59M | $1.57M | $6.38M | $1.61M |
| Operating Profit | -$13.45M | -$51.14M | -$62.77M | -$169.24M | -$36.03M |
| Net Non-Operating Interest Income (Expense) | -$1.72M | -$1.54M | -$1.19M | -$6.56M | -$1.17M |
| Non-Operating Interest Expense | $1.72M | $1.54M | $1.19M | $6.56M | $1.17M |
| Other Income (Expense) | $2.38M | $1.50M | -$590,000.00 | -$7.91M | $9.07M |
| Special Income (Charges) | $2.38M | $1.50M | -$590,000.00 | -$7.91M | $9.07M |
| -Less:Restructuring and Mergern & Acquisition | -$2.38M | -$1.50M | $590,000.00 | -$2.47M | -$9.07M |
| Pretax Profit | -$12.79M | -$51.19M | -$64.54M | -$183.70M | -$28.13M |
| Tax | $88,000.00 | $128,000.00 | $0.00 | -$530,000.00 | $430,000.00 |
| Net Profit | -$12.88M | -$51.31M | -$64.54M | -$183.17M | -$28.56M |
| Profit from Continuing Operations | -$12.88M | -$51.31M | -$64.54M | -$183.17M | -$28.56M |
| Net Income to Parent Company | -$12.88M | -$51.31M | -$64.54M | -$183.17M | -$28.56M |
| Net Income to Common Stockholders | -$12.88M | -$51.31M | -$64.54M | -$183.17M | -$28.56M |
| Basic EPS | -$0.25 | -$0.99 | -$1.26 | -$3.68 | -$0.56 |
| Diluted EPS | -$0.25 | -$0.99 | -$1.26 | -$3.68 | -$0.56 |
| -Less:Other Special Charges | – | – | – | $10.39M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $826.77M | $761.45M | $713.61M | $689.81M | $689.81M |
| Total Current Assets | $724.64M | $656.57M | $611.21M | $588.99M | $588.99M |
| Cash and Cash Equivalents & Short-Term Investments | $313.86M | $319.85M | $305.11M | $322.93M | $322.93M |
| -Cash and Cash Equivalents | $313.86M | $319.85M | $305.11M | $322.93M | $322.93M |
| Receivables | $343.11M | $277.46M | $251.06M | $224.46M | $224.46M |
| -Accounts Receivable | $343.11M | $277.46M | $251.06M | $224.46M | $224.46M |
| Inventory | $42.58M | $37.88M | $31.52M | $27.94M | $27.94M |
| Other Current Assets | $25.08M | $21.38M | $23.52M | $13.65M | $13.65M |
| Total Non-Current Assets | $102.14M | $104.88M | $102.40M | $100.82M | $100.82M |
| Net PPE | $19.23M | $20.03M | $20.58M | $21.42M | $21.42M |
| -Gross PPE | $19.23M | $20.03M | $20.58M | $21.42M | $21.42M |
| Goodwill and Other Intangible Assets | $47.79M | $49.40M | $50.99M | $52.56M | $52.56M |
| -Goodwill | $12.04M | $12.04M | $12.04M | $12.04M | $12.04M |
| -Other Intangible Assets | $35.75M | $37.36M | $38.95M | $40.52M | $40.52M |
| Other Non-Current Assets | $35.12M | $35.45M | $30.83M | $26.84M | $26.84M |
| Total Liabilities | $721.34M | $678.14M | $659.02M | $601.51M | $601.51M |
| Total Current Liabilities | $509.72M | $460.45M | $439.21M | $378.84M | $378.84M |
| Payables | $96.08M | $78.97M | $106.80M | $65.64M | $65.64M |
| -Accounts Payable | $96.08M | $78.97M | $106.70M | $65.54M | $65.54M |
| -Total Tax Payable | $0.00 | $0.00 | $99,000.00 | $101,000.00 | $101,000.00 |
| Current Accrued Expenses | $284.34M | $261.21M | $220.42M | $193.27M | $193.27M |
| Short-Term Debt and Capital Lease Obligation | $76.22M | $76.13M | $73.82M | $72.98M | $72.98M |
| -Current Debt | $70.00M | $70.00M | $70.00M | $70.00M | $70.00M |
| -Current Capital Lease Obligation | $6.22M | $6.13M | $3.82M | $2.98M | $2.98M |
| Other Current Liabilities | $11.23M | $11.20M | $11.15M | $10.01M | $10.01M |
| Total Non-Current Liabilities | $211.62M | $217.70M | $219.81M | $222.67M | $222.67M |
| Long Term Debt and Capital Lease Obligation | $148.01M | $148.56M | $146.08M | $145.13M | $145.13M |
| -Long Term Debt | $118.07M | $117.96M | $117.85M | $117.75M | $117.75M |
| -Long Term Capital Lease Obligation | $29.94M | $30.60M | $28.23M | $27.39M | $27.39M |
| Other Non-Current Liabilities | $63.61M | $69.14M | $73.73M | $77.54M | $77.54M |
| Total Equity | $105.43M | $83.30M | $54.59M | $88.30M | $88.30M |
| Stockholders' Equity | $105.43M | $83.30M | $54.59M | $88.30M | $88.30M |
| Capital Stock | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 |
| -Common Stock | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.54B | $1.51B | $1.43B | $1.39B | $1.39B |
| Retained Earnings | -$1.43B | -$1.42B | -$1.37B | -$1.31B | -$1.31B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$9.47M | -$32.95M | -$20.70M | -$93.41M | -$18.65M |
| Net cash flow from continuing operations | -$9.47M | -$32.95M | -$20.70M | -$93.41M | -$18.65M |
| Net Income from Continuing Operations | -$12.88M | -$51.31M | -$64.54M | -$183.17M | -$28.56M |
| Depreciation & Depletion & Amortization | $3.06M | $2.89M | $2.37M | $9.06M | $2.27M |
| Other Non-Cash Items | -$2.15M | -$1.26M | $985,000.00 | -$909,000.00 | -$8.27M |
| Change in Working Capital | -$23.86M | -$10.41M | $17.05M | -$22.52M | -$6.83M |
| -Change in Receivables | -$65.66M | -$26.40M | -$26.60M | -$82.46M | -$27.96M |
| -Change in Inventory | -$3.66M | -$5.04M | -$4.87M | -$15.67M | -$3.49M |
| -Change in Prepaid Assets | -$3.71M | $2.15M | -$9.87M | -$1.67M | $6.14M |
| -Change in Payables and Accrued Expense | $49.16M | $18.88M | $58.39M | $77.28M | $18.48M |
| Net cash flow from investing | -$197,000.00 | -$450,000.00 | -$121,000.00 | -$480,000.00 | -$71,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$197,000.00 | -$450,000.00 | -$121,000.00 | -$480,000.00 | -$71,000.00 |
| Net PPE Purchase and Sale | -$197,000.00 | -$450,000.00 | -$121,000.00 | -$480,000.00 | -$71,000.00 |
| Financing Cash Flow | $3.68M | $48.15M | $2.99M | $101.47M | $16.39M |
| Net Cash Flow from Continuing Financing Activities | $3.68M | $48.15M | $2.99M | $101.47M | $16.39M |
| Net Issuance Payments Of Debt | -$1.42M | -$1.21M | -$672,000.00 | -$4.11M | -$541,000.00 |
| Net Common Stock Issuance | $0.00 | $13.47M | $6.34M | $67.90M | $5.68M |
| Proceeds from Stock Option Exercised | $10.06M | $41.97M | $9.98M | $59.56M | $15.34M |
| Net Other Financing Charges | -$4.96M | -$6.09M | -$12.66M | -$21.89M | -$4.09M |
| Ending Cash Balance | $313.86M | $319.85M | $305.11M | $322.93M | $322.93M |
| Net Change in Cash | -$5.99M | $14.74M | -$17.83M | $7.58M | -$2.34M |
| Beginning Cash Balance | $319.85M | $305.11M | $322.93M | $315.35M | $325.27M |
| Free Cash Flow | -$9.67M | -$33.40M | -$20.82M | -$93.89M | -$18.72M |
| Gain/Loss from Continuing Operations | – | – | – | $10.39M | $0.00 |
No comments yet — be the first to weigh in on AXSM.
Sign in to join the discussion.